Cannabis Cardiol Therapeutics Inc. Completes US$13.5 Million Public Offering of Common SharesBy Alexander LeeOctober 10, 20240 On October 10, 2024, Cardiol Therapeutics Inc., a clinical-stage life sciences company focused on researching and developing anti-inflammatory and anti-fibrotic…
Cannabis Akanda Corporation Announces Pricing of Underwritten Public OfferingBy Alexander LeeOctober 5, 20240 On October 2, 2024, Akanda Corp. announced that it has entered into a firm commitment underwriting agreement with Univest Securities,…
Cannabis Akanda Corporation Declares Completion of Underwritten Public OfferingBy Alexander LeeOctober 4, 20240 October 04, 2024 8:30 AM EDT | Source: Akanda Corp London, United Kingdom–(Newsfile Corp. – October 4, 2024) -…
